Objectives: To investigate the prevalence of metallo-b-lactamases (MBLs) and Tn6001 in carbapenemnon-susceptible Pseudomonas aeruginosa (CNSPA). The CNSPA included extensively drug-resistant P. aeruginosa (XDRPA) and non-XDRPA isolates in Taiwan.
Introduction
Carbapenem resistance in Pseudomonas aeruginosa has become more common in many countries and is correlated with multidrug resistance (MDR). It is known that carbapenem resistance in P. aeruginosa is usually associated with decreased permeability, efflux pump up-regulation and/or the production of metallob-lactamases (MBLs). 1 -3 Different types of MBL have been identified, including IMP, VIM, GIM, SIM and SPM. 2, 3 The VIM-3 MBL was first reported in Taiwan in 2001 and was later found on gene cassettes of the class 1 integron. 1, 4, 5, 7 Recently, we reported a transposon, Tn6001, which contains a bla VIM-3 - harbouring integron In450, in a clinical isolate of extensively drug-resistant (XDR) P. aeruginosa (XDRPA). 6 However, the overall prevalence of In450 and Tn6001 in VIM-3-carrying carbapenem-non-susceptible P. aeruginosa (CNSPA) is unknown.
Materials and methods

Bacterial isolates
The 308 non-duplicate CNSPA isolates, defined as isolates resistant to imipenem or meropenem, were collected from 2000 to 2005 at the National Taiwan University Hospital (NTUH), a 2500 bed medical centre in northern Taiwan. If more than one isolate of CNSPA was recovered from the same patient, only the first isolate was included. One of the 308 isolates, NTUH-PA450, was previously reported to carry a transposon Tn6001. 6 
Antimicrobial susceptibility testing
MICs of nine antimicrobial agents were determined using an agar dilution method according to CLSI guidelines. 8 The following antimicrobial agents were provided by their manufacturers for use in this study: piperacillin/tazobactam, ceftazidime, cefepime, aztreonam, amikacin, ciprofloxacin, imipenem, meropenem and colistin. XDRPA was defined as P. aeruginosa isolates resistant to antimicrobial agents piperacillin/tazobactam, ceftazidime, cefepime, aztreonam, amikacin, ciprofloxacin, imipenem and meropenem, and susceptible or intermediately resistant to colistin.
Detection of MBL genes by PCR amplification and sequencing
PCR amplification of MBL genes, including bla IMP-1-9 , bla VIM-1 and bla VIM-2 genes, was performed according to previously reported protocols [Table S1 , available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/)]. 4, 9 The types of MBL were confirmed by sequence.
Detection of Tn6001 and bla VIM-2 -harbouring integron cassette by multiplex PCR
The dissemination of Tn6001 in clinical isolates was detected by multiplex PCR (the primers are listed in Table S1 ) targeting the junctions of the In450 and Tn6001 backbone structure (GenBank accession number EF138817). The amplicon sizes and locations are shown in Figure 1 (a). The bla VIM-2 -harbouring integron cassette was detected by two sets of PCR ( Figure 1b ) and confirmed by sequencing.
Genotyping by PFGE
Genotypes of 109 of the 308 CNSPA isolates (30 isolates of XDRPA, including 27 COS P. aeruginosa and 3 COI P. aeruginosa, and 79 bla VIM-2 and bla VIM-3 -producing non-XDR CNSPA) from NTUH and 26 XDRPA from six medical centres were determined by PFGE. PFGE analysis was carried out as described previously. 1
Southern blot hybridization
The SpeI-digested chromosome fragments of four clinical isolates were analysed by PFGE. The PFGE gel was then subjected to Southern blotting and hybridized with a DIG (digoxigenin)labelled bla VIM-3 -specific probe. The hybridization assay was performed as described previously. 10 
Results
Antimicrobial susceptibility of CNSPA isolates from NTUH A high percentage of cross-resistance to ceftazidime (66%-89%) and cefepime (63%-90%) was found in the CNSPA isolates [ Table S2 , available as Supplementary data at JAC Online (http:// jac.oxfordjournals.org/)]. The rate of resistance to monobactam (aztreonam) was also high (52%-90%). It is noted that resistance to ciprofloxacin increased quickly from 2002 to 2004 (76%-93%) while resistance to amikacin ranged from 24% to 56% and there was no resistance to colistin noted in these isolates. Difficulty in treating COS and COI P. aeruginosa was found from 2003 to 2005, but the percentages (11%-19% and 0%-3%, respectively) were low. Neither a significant increase in the prevalence of COS or COI P. aeruginosa nor shifts of resistance to categories of medically useful antibiotics were noted.
Distribution of MBL genes, integron cassette and Tn6001
bla VIM-2 and bla VIM-3 genes were detected in 6 (1.9%) and 88 (28.6%) of the 308 CNSPA from NTUH. The prevalence of the bla VIM-3 gene ranged from 13% to 32% in non-XDRPA isolates collected during 2000 -05 except in 2002. The prevalence of the bla VIM-3 gene was exceptionally high (52%) in 2002 (Table 1) . COS and COI P. aeruginosa were first isolated in 2003 and persisted in 2004 and 2005. Furthermore, significant increases in VIM-3 (40% to 67%), In450 (40% to 56%) and Tn6001 (40% to 50%) from 2003 to 2005 were also noted among COS isolates. Six CNSPA carried a bla VIM-2 -harbouring integron cassette ( Figure 1b ). Of these integrons, four were identical to AY943084, whereas two (04-14 and 05-43) contained different types of bla VIM-2 -harbouring integron. bla VIM-2 and bla VIM-3 genes were detected in 4 (15.4%) and 16 (61.5%) of the 26 XDRPA isolates collected from six medical centres in Taiwan. Twenty-five (96%) were COS and only one (4%) was COI [ Table S3 , available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/)]. Neither In450 nor Tn6001 was found in the COI isolate. High percentages of In450 and Tn6001 [100% (11/11) and 64% (7/11), respectively] were detected in COS isolates from hospital N1. Similar high percentages (4/10, 40%) were also noted in hospital N2. These findings suggest that the high prevalences of In450 and Tn6001 are associated with MDR P. aeruginosa in Taiwan.
PFGE analysis
PFGE analysis of the 135 P. aeruginosa isolates revealed 60 different pulsotypes. There were 51 different pulsotypes found in 109 CNSPA isolates from NTUH and 16 from 26 XDRPA from six medical centres (seven pulsotypes were distributed among isolates from both NTUH and six medical centres). Four of 15 pulsotypes from the 30 XDRPA isolates and 18 of 49 pulsotypes from 79 non-XDR CNSPA from NTUH and 5 of 16 pulsotypes of the 26 XDRPA from six medical centres had multiple isolates (2 isolates).
Structures of two variants of In450
Two variant structures of In450 were found in three non-XDRPA isolates. One integron cassette, designated In450.1, contained the following seven genes: bla VIM-3 , orf2, three copies of aacA4, aadB and a copy of aacA4. The other integron cassette, designated In450.2, contained the following five genes: bla VIM-3 , orf2, aacA4, aadB and a copy of aacA4 (Figure 1a ). Both In450.1 and In450.2 were harboured in the Tn6001 backbone structure, designated Tn6001.1 and Tn6001.2, respectively (Figure 1a ).
Mobile DNA Tn6001
Although it was difficult to demonstrate that gene transfer had occurred in the MDR isolate, the results from two closely related clinical isolates from patient A could support the transfer of Tn6001. In patient A, an imipenem-susceptible isolate (MIC, 0.12 mg/L) recovered 3 months before the isolation of the carbapenem-resistant isolate (MIC, .32 mg/L) was used for comparison. PFGE/hybridization analysis revealed only a one band difference between these two isolates [ Figure S1a , lanes 1 and 2, available as Supplementary data at JAC Online (http:// jac.oxfordjournals.org/)]. This DNA fragment contained the bla VIM-3 gene, which was associated with imipenem resistance ( Figure S1b, lanes 1 and 2) . Furthermore, this imipenemresistant isolate showed the presence of Tn6001 by multiplex PCR. These findings indicate that the second clinical isolate developed its imipenem resistance phenotype through DNA acquisition and was probably transferred by transposon.
Discussion
Consistent with previous studies, the bla VIM-3 gene was the most common MBL gene in MBL-producing P. aeruginosa isolates in Taiwan and was usually harboured by class 1 integrons. 1, 4, 5 The prevalence of bla VIM-3 in COI or COS P. aeruginosa was higher than that in non-XDRPA isolates. Higher prevalences of In450 and Tn6001 were also detected in COI and COS isolates, both from NTUH and from the six hospitals located in various areas in Taiwan (Tables 1 and S3 ). These findings indicate that In450 and Tn6001 may account for the transfer of drug resistance genes. However, other mechanisms may also play a role. Since as high as 52% (11/21) of CNSPA contained bla VIM-3 in 2002, but only a disproportionately low percentage (24%, 5/21) of them carried In450 and 14% (3/21) carried Tn6001. These results suggest that unknown mechanisms other than In450 and Tn6001 may be responsible for the spread of bla VIM-3 .
Tn6001 was found in different pulsotypes of P. aeruginosa isolates. Although it is difficult to demonstrate the gene transfer property of Tn6001 in the laboratory, results from this study still provide two pieces of evidence supporting the possibility that Tn6001 is a mobile DNA element and thus disseminated among different isolates. First, the finding that there was only one band difference identified by PFGE and hybridization with a bla VIM-3 -specific probe may suggest that Tn6001 could be acquired by a susceptible isolate and thus become resistant ( Figure S1 ). Second, the heterogeneity of pulsotypes for Tn6001-containing P. aeruginosa isolates revealed polyclonal relatedness, suggesting that horizontal transfer may have occurred. However, several isolates recovered from NTUH (2000 -05) and six medical centres (2003) exhibited identical pulsotypes and contained Tn6001 suggesting the presence of intra-hospital and inter-hospital clonal dissemination.
In addition, Yan et al. 5 described that after digestion with EcoRI in MDR P. aeruginosa isolates, there were three different DNA fragments (6.2, 6.6 and 8.8 kb) found with a bla VIM-3specific probe. These isolates all contained Tn6001 and one EcoRI site (position 5942 of GenBank accession number EF138817), which was located at orf2 downstream of bla VIM-3 . This finding suggested that the three different patterns of EcoRI-digested DNA fragments found by Yan et al. 5 were due to different locations of Tn6001 integration. These inferences suggest that the distribution of Tn6001 might be associated with horizontal transfer. XDRPA formation may involve antibiotic resistance mechanisms other than Tn6001 dissemination. A high percentage of aztreonam resistance could be correlated with bla OXA-10 and bla OXA-17 spreading, 5 whereas fluoroquinolone resistance has been linked to amino acid changes in topoisomerase types II and IV. We also found that mutations in GyrA (Thr-83!Ile) and ParC (Ser-87!Leu) in the quinolone resistance-determining region may be associated with quinolone resistance (data not shown). Thus, further characterization of XDRPA isolates is a priority and an important issue in Taiwan.
